103 related articles for article (PubMed ID: 24133905)
1. Cytokine promoter polymorphisms and risk of colorectal cancer.
Burada F; Dumitrescu T; Nicoli R; Ciurea ME; Rogoveanu I; Ioana M
Clin Lab; 2013; 59(7-8):773-9. PubMed ID: 24133905
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
3. ASSOCIATION OF PROMOTER REGION POLYMORPHISMS OF INTERLEUKIN-10 GENE WITH SUSCEPTIBILITY TO COLORECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Mirjalili SA; Moghimi M; Aghili K; Jafari M; Abolbaghaei SM; Neamatzadeh H; Mazaheri M; Zare-Shehneh M
Arq Gastroenterol; 2018; 55(3):306-313. PubMed ID: 30540096
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study of cytokine gene polymorphism effects on Saudi patients with colorectal cancer.
Althubyani SA; Alkhuriji AF; Al Omar SY; El-Khadragy MF
Saudi Med J; 2020 Dec; 41(12):1292-1300. PubMed ID: 33294886
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 receptor -3223T→C polymorphism is associated with increased gastric adenocarcinoma risk.
Burada F; Angelescu C; Mitrut P; Ciurea T; Cruce M; Saftoiu A; Ioana M
Can J Gastroenterol; 2012 Aug; 26(8):532-6. PubMed ID: 22891178
[TBL] [Abstract][Full Text] [Related]
6. Association of cytokine gene polymorphisms with osteoarthritis susceptibility.
Rogoveanu OC; Calina D; Cucu MG; Burada F; Docea AO; Sosoi S; Stefan E; Ioana M; Burada E
Exp Ther Med; 2018 Sep; 16(3):2659-2664. PubMed ID: 30186498
[TBL] [Abstract][Full Text] [Related]
7. Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression.
Miteva LD; Stanilov NS; Deliysky TS; Stanilova SA
Tumour Biol; 2014 Dec; 35(12):12655-64. PubMed ID: 25209180
[TBL] [Abstract][Full Text] [Related]
8. Mitogen/extracellular signal-regulated kinase kinase-5 promoter region polymorphisms affect the risk of sporadic colorectal cancer in a southern Chinese population.
Diao D; Wang L; Zhang JX; Chen D; Liu H; Wei Y; Lu J; Peng J; Wang J
DNA Cell Biol; 2012 Mar; 31(3):342-9. PubMed ID: 21861603
[TBL] [Abstract][Full Text] [Related]
9. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.
Proença MA; de Oliveira JG; Cadamuro AC; Succi M; Netinho JG; Goloni-Bertolo EM; Pavarino ÉC; Silva AE
World J Gastroenterol; 2015 Jul; 21(25):7730-41. PubMed ID: 26167073
[TBL] [Abstract][Full Text] [Related]
10. Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity.
Chen D; Song S; Lu J; Luo Y; Yang Z; Huang Q; Fu X; Fan X; Wei Y; Wang J; Wang L
Carcinogenesis; 2011 Jul; 32(7):1043-9. PubMed ID: 21393476
[TBL] [Abstract][Full Text] [Related]
11. Two variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study.
Qian H; Zhang D; Bao C
Aging (Albany NY); 2018 Dec; 10(12):4084-4092. PubMed ID: 30563955
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
13. Association of PARK2 promoter polymorphisms and methylation with colorectal cancer in North Indian population.
Bhat ZI; Kumar B; Bansal S; Naseem A; Tiwari RR; Wahabi K; Sharma GD; Alam Rizvi MM
Gene; 2019 Jan; 682():25-32. PubMed ID: 30296568
[TBL] [Abstract][Full Text] [Related]
14. A functional polymorphism in the promoter region of
Li ZH; Han BW; Zhang XF
Biomark Med; 2019 May; 13(7):567-575. PubMed ID: 31140826
[No Abstract] [Full Text] [Related]
15. Polymorphisms of tumor necrosis factor alpha in Middle Eastern population with colorectal cancer.
Hamadien MA; Khan Z; Vaali-Mohammed MA; Zubaidi A; Al-Khayal K; McKerrow J; Al-Obeed O
Tumour Biol; 2016 Apr; 37(4):5529-37. PubMed ID: 26572151
[TBL] [Abstract][Full Text] [Related]
16. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
[TBL] [Abstract][Full Text] [Related]
17. Influence of TNF-α promoter variability on stage and grade in individuals with colorectal cancer.
Natkaniec M; Dworak J; Hankus J; Sanak M; Pędziwiatr M; Major P; Lichołai S; Budzyński A
Pol J Pathol; 2018; 69(2):150-156. PubMed ID: 30351862
[TBL] [Abstract][Full Text] [Related]
18. Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer.
Tan SC; Suzairi MS; Aizat AA; Aminudin MM; Nurfatimah MS; Bhavaraju VM; Biswal BM; Ankathil R
Med Oncol; 2013 Dec; 30(4):693. PubMed ID: 23996241
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk.
Zhang YM; Zhou XC; Xu Z; Tang CJ
Genet Mol Res; 2012 Sep; 11(3):3389-97. PubMed ID: 23079832
[TBL] [Abstract][Full Text] [Related]
20. CDH1 promoter polymorphism (-347G-->GA) is a possible prognostic factor in sporadic colorectal cancer.
Zou XP; Dai WJ; Cao J
World J Gastroenterol; 2009 Nov; 15(42):5340-5. PubMed ID: 19908344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
